Showing results (1-10 of 2,977) with videos related to
Sort By:
Pageof 298
Hematology/Oncology Clinics of North America|November 1, 2019
Nanotechnology in Radiation OncologyBo Sun, C Tilden Hagan, Joseph Caster, et al.Advances in Cancer Research|June 27, 2018
Nanotechnology Approaches to Improving Cancer ImmunotherapyC Tilden Hagan, Yusra B Medik, Andrew Z WangBioconjugate Chemistry|November 30, 2020
Enhancing Combined Immunotherapy and Radiotherapy through NanomedicineC Tilden Hagan, Yu Mi, Nicole M Knape, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 3, 2019
Emerging Nano-/Microapproaches for Cancer ImmunotherapyYu Mi, C Tilden Hagan, Benjamin G Vincent, et al.Journal of Materials Chemistry. B|September 5, 2017
Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer modelsJing Tian, Yuanzeng Min, Zachary Rodgers, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2022
3D printed drug-loaded implantable devices for intraoperative treatment of cancerC Tilden Hagan, Cameron Bloomquist, Samuel Warner, et al.Acta Biomaterialia|June 20, 2022
Continuous liquid interface production of 3D printed drug-loaded spacers to improve prostate cancer brachytherapy treatmentC Tilden Hagan, Cameron Bloomquist, Isaiah Kim, et al.Acta Pharmacologica Sinica|May 20, 2020
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironmentBo Sun, Hyesun Hyun, Lian-Tao Li, et al.Acta Biomaterialia|February 8, 2021
Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer modelsMaofan Zhang, C Tilden Hagan, Hayley Foley, et al.Biomaterials|April 10, 2018
Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer modelsMaofan Zhang, C Tilden Hagan, Yuangzeng Min, et al.Pageof 298